Upstate Active Clinical Trials
Study Title:
AHOD2131 – A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin LymphomaWhat is the purpose of the study? (in Layman's terms, please describe the study)
Treatment for Newly Diagnosed Stage I and II Classic Hodgkin LymphomaUpstate Institutional Review Board (IRB) Number:
2066742Study/Protocol ID:
AHOD2131Study Phase:
3Patient Age Group:
ChildrenPrincipal Investigator:
Philip MonteleoneWho is eligible?
Less than or equal to 21 years of age with newly diagnosed Stage I and II Classic Hodgkin LymphomaWhat is involved if I participate?
- How long is the study?
until accrual is met - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
standard of care tests and procedures
Where will the study take place?
University Hospital DowntownCancer Center
Other Information:
NoneWho can I contact for more information?
Name: Karen B Bilynsky
Phone: 315-464-7601
Email: [email protected]